Advances in Bone Cancer Treatment: Preventing Metastasis and Bone Loss
CME Monograph - February 2010
Overview
Medical professionals who assess, treat and/or counsel cancer patients need to be able to assess and discuss new clinical data and recommendations related to the use of bone-targeted therapies to treat and prevent bone metastasis and prevent bone loss related to cancer treatment, and integrate this information into their own practice.
Target Audience
This educational activity is intended for oncologists, urologists, and other medical professionals who assess, treat, or counsel cancer patients.
Faculty
Robert E. Coleman, MD, FRCP
Cancer Research Centre, Weston Park Hospital, Sheffield, UK
Theresa A. Guise, MD
Professor of Medicine Indiana University School of Medicine, Indianapolis, IN
Ingunn Holen, BSc, MSc, PhD
University of Sheffield Medical School, Sheffield, UK
Allan Lipton, MD
Professor of Medicine and Oncology, Penn State University, Hershey, PA
G. David Roodman, MD, PhD
VA Pittsburgh Healthcare System, Pittsburgh, PA
Educational Grant Support
This program is supported by educational grants provided by Amgen, Inc. and Novartis Pharmaceuticals.
Sponsorship
CME sponsorship and program management were provided by InforMEDical.
The online CME activity is effective March 2010 through February 2011.
